Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Neurosurgery: Patient Selection and Communication
The Doctors Company conducted an analysis of medical malpractice claims against neurosurgeons that closed between the years of 2014 and 2019. This evaluation included 302 claims and lawsuits, and examined allegations, diagnoses, procedures, and contributing factors, as well as indemnities and expenses paid. The claims experience of neurosurgeon members of The Doctors Company was then benchmarked against a national sample of other neurosurgeons.
Subscriber Agreement and Power of Attorney
The Doctors Company's subscriber agreement for power of attorney.
July 14, 2025, Medical Economics
Why Only 12% of Physicians Would Choose Medicine Again
The Doctors Company's latest "Future of Healthcare" survey paints a sobering picture of physician morale and the medical industry in 2025. With an overall Net Promoter Score (NPS) of -52, only 12% of physicians said they would recommend medicine as a career path.
Subscriber Agreement
Subscriber agreement for The Doctors Company.
Video Oct 28, 2021
Clinical Support Tools for the Emergency Department
Emergency department systems and processes can increase or reduce the risk of diagnostic error. But instead of simply asking clinicians to work harder or smarter, what’s needed is the creation of a system of care that optimizes their ability to think and carry out an efficient work-up of a patient. Learn more from Jacqueline Ross, PhD, RN, CPAN, our coding director.
February 24, 2024, Risk Management and Healthcare Policy
Analysis of Closed Claims Among All Medical Specialties: Importance of Communication and Other Non-Clinical Contributing Factors
Evaluation of contributing factors associated with medical malpractice claims provides important information to optimize the patient–provider relationship. This review of closed claims from The Doctors Company highlights common factors contributing to lawsuits and strategies to avoid them, with a particular focus on communication.
Chairman’s Letter to JAMA Editor
Letter to the editor of JAMA written by Dr. Richard E. Anderson, chairman of The Doctors Company Board of Governors, praising the critique of the IOM report on medical errors in the JAMA article by Clement J. McDonald, MD, et al., “Deaths Due to Medical Errors Are Exaggerated in IOM Report.”
New Models of Personalized Tech-Enabled Care Delivery
Ami Parekh, MD, JD, Chief Health Officer, Included Health, and Member, Board of Governors, The Doctors Company, Part of TDC Group, presents at the 2025 TDC Group Executive Advisory Board Meeting about Included Health's work to raise the standard of healthcare through all-in-one personalized healthcare.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate